Rhodium-Catalyzed Asymmetric Cyclodimerization
1H), 5.26 (d, J ) 7.3 Hz, 1H), 4.42 (d, J ) 6.4 Hz, 1H), 3.35 (m,
1H), 3.06 (dd, J ) 9.5, 6.5 Hz, 1H); 13C NMR (APT, CDCl3, 100
MHz, observed signals) δ 147.3 (apt d), 144.7 (apt t), 142.2 (m),
141.3 (m), 140.7 (m) 139.7 (m), 138.7 (m), 138.2 (m), 127.4, 127.2
(minor enantiomer) and 13.14 min (major enantiomer), 98% ee;
[R]25D ) +47.0 (c ) 0.52, CHCl3); 1H NMR (acetone-d6, 400 MHz,
40 °C) δ 7.45-6.85 (m, 8H), 6.57 (br s, 1H), 5.94 (dd, J ) 9.7,
5.5 Hz, 1H), 5.52 (d, J ) 11.2 Hz, 1H), 4.82 (s, 1H), 4.75 (br s,
1H), 4.17 (br s, 1H), 3.23 (m, 1H), 2.55 (apt t, J ) 7.4 Hz, 1H),
1.57 (s, 9H), 0.99 (s, 9H); 13C NMR (APT, HSQC, acetone-d6,
100 MHz, 40 °C) δ 205.8 (2), 155.6, 137.3, 132.3 (2), 129.7, 128.6,
127.6, 127.4, 127.2, 127.0, 124.8, 122.2, 121.3, 120.5, 80.2, 79.1,
67.4, 64.6, 63.7, 60.1, 53.5, 40.0, 28.8, 28.2; IR (NaCl, cm-1) 3055
(w), 2976 (m), 2931 (m), 1693 (s), 1478 (m), 1456 (m), 1289 (w),
1252 (w), 1229 (w), 1169 (s), 1152, 1113 (m), 941 (w), 785 (w),
752 (w), 737 (w), 702 (w). Anal. Calcd for C30H34N2O4: C, 74.05;
H, 7.04. Found: C, 74.41; H, 6.98.
Oxabenzonorbornenol 9 (Scheme 11). To an oven-dried, round-
bottom flask were added 8a (200.1 mg, 0.694 mmol), p-toluene-
sulfonic acid monohydrate (55.7 mg, 0.293 mmol), and 1,2-
dichloroethane (3.5 mL). The mixture was stirred under argon for
5.5 h and then concentrated by rotary evaporation. The crude
product was purified using column chromatography (1:4 EtOAc/
hexanes, Rf ) 0.29) to obtain 9 as a white solid (199.8 mg, 0.693,
99%). Spectroscopic data for 9 was in agreement with values
reported in the literature:7b 1H NMR (CDCl3, 400 MHz) δ 7.93 (s,
1H), 7.89 (m, 3H), 7.50 (m, 3H), 7.41 (m, 1H), 7.28 (m, 3H), 5.60
(s, 1H), 5.35 (s, 1H), 4.31 (apt t, J ) 7.8 Hz, 1H), 3.44 (d, J ) 7.0
Hz, 1H), 1.58 (d, J ) 8.8 Hz, 1H); 13C NMR (APT, CDCl3, 75
MHz) δ 146.6, 142.6, 135.0, 133.5, 132.6, 128.6, 127.8, 127.6,
127.54, 127.48 (2), 127.0, 126.4, 126.0, 120.9, 119.1, 86.0, 84.5,
74.2, 51.8; IR (NaCl, cm-1) 3555 (w), 3436 (w), 3052 (w), 2999
(w), 2941 (w), 1632 (w), 1600 (w), 1507 (w), 1460 (w), 1347 (w),
1269 (w), 1213 (w), 1191 (w), 1153 (w), 1068 (m), 995 (w), 982
(w), 942 (w), 907 (w), 826 (m), 810 (m), 784 (w), 757 (m), 741
(m); HRMS (CI) calcd for C20H16O2 (M+) 288.1150, found
288.1140.
2
2
(d, JC-F ) 17.9 Hz), 124.6 (d, JC-F ) 18.8 Hz), 116.8, 116.7,
114.2 (2JC-F ) 13.7 Hz), 81.8, 80.8, 76.9, 73.7, 51.6, 38.3; 19F
NMR (CDCl3, 377 MHz) δ -147.9 (apt t, J ) 20.4 Hz, 1F), -149.3
(apt t, J ) 20.6 Hz, 1F), -152.7 (dd, J ) 13.6, 20.5 Hz, 1F), -155.4
(dd, J ) 13.4, 20.5 Hz, 1F), -160.7 (apt t, J ) 19.8 Hz, 1F), -161.1
(apt t, J ) 19.7 Hz, 1F), -162.8 (apt t, J ) 19.2 Hz, 1F), -164.1
(apt t, J ) 20.3 Hz, 1F); IR (NaCl, cm-1) 2958 (m), 2925 (m),
2854 (m), 1507 (m), 1488 (m), 1466 (w), 1423 (w), 1387 (w), 1378
(w), 1292 (w), 1125 (w), 1073 (w), 1046 (w), 1012 (w), 975 (w),
944 (w), 877 (w), 823 (w); HRMS (CI) calcd for C20H8F8O2 (M+)
432.0397, found 432.0390.
Perfluoronaphthol 12 (Scheme 6). Performed according to the
general procedure using oxabenzonorbornadiene 1g (60.9 mg, 0.282
mmol) and heating for 30 min. The crude product was purified by
column chromatography to obtain 12 (1:9 EtOAc/hexanes, Rf )
0.51): 19.5 mg, 0.045 mmol, 32%, white solid, mp 156-157 °C,
HPLC (Chrial Technologies Chiralcel OB-H column, 99:1 hexanes/
2-propanol, 0.05 mL/min, 220 nm) retention times of 194.86 min
(major enantiomer) and 235.11 min (minor enantiomer), 93% ee;
1
[R]26 ) +17.9 (c ) 0.27, CHCl3); H NMR (CDCl3, 400 MHz)
D
δ 7.86 (d, JH-F ) 9.9 Hz, 1H, OH), 7.56 (dd, J ) 8.7, 1.6 Hz, 1H),
7.49 (d, J ) 8.8 Hz, 1H), 5.95 (m, 1H), 5.70 (d, JH-F ) 1.6 Hz,
1H), 3.46 (dd, J ) 4.7, 8.7 Hz, 1H), 2.29 (m, 1H), 2.20 (m, 1H);
13C NMR (APT, CDCl3, 75 MHz) δ 148.6 (m), 144.9 (m), 143.7
(m), 141.7 (m), 140.4 (m), 139.4 (m), 138.5 (m), 136.0 (m)
2
(preceding signals account for 8 ipso-F C), 128.8, 127.0 (d, JC-F
) 17.8 Hz), 126.9 (d, 2JC-F ) 17.0 Hz), 124.9 (ipso-OH C), 120.7
2
(d, JC-F ) 13.7 Hz), 111.9, 110.6 (m), 81.7, 77.8, 40.3, 35.2; IR
(NaCl, cm-1) 3174 (m), 2958 (w), 2924 (m), 2854 (w), 1665 (w),
1622 (w), 1591 (w), 1524 (w), 1507 (m), 1490 (m), 1463 (w), 1411
(m), 1333 (w), 1319 (w), 1309 (w), 1287 (w), 1273 (w), 1252 (w),
1184 (w), 1136 (w), 1114 (w), 1075 (w), 1043 (w), 1020 (w), 987
(w), 972 (w), 923 (w), 903 (w), 876 (w), 854 (w), 816 (w), 804
(w), 761 (w), 719 (w); HRMS (CI) calcd for C20H8F8O2 (M+)
432.0397, found 432.0395. Characterized also by HSQC and 2D
COSY NMR experiments.
Acknowledgment. This work was supported by NSERC
(Canada) and Boehringer Ingelheim (Canada). W.T. thanks
Boehringer Ingelheim (Canada) Ltd. for a Young Investigator
Award, A.A., P.L., and K.V. thank NSERC for postgraduate
scholarships (CGS M, PGS M, and CGS D), and R.B. thanks
the Ontario Government for a postgraduate scholarship (OGS).
Cyclodimerization Product 28a (Table 10, Entry 1, R1 ) R2
) H, R3 ) Boc). Performed according to the general procedure
using azabenzonorbornadiene 27a (67.6 mg, 0.278 mmol) and
heating for 20 h. The crude product was purified by column
chromatography (1:4 EtOAc/hexanes, Rf ) 0.39) to obtain 28a as
a light brown solid (59.6 mg, 0.122 mmol, 88%): mp 70 °C dec;
HPLC using a Chiralcel OD-H column, retention times of 8.83 min
Supporting Information Available: Detailed experimental
procedures and full characterization of all new compounds. This
material is available free of charge via the Internet at http://
pubs.acs.org.
JO7012884
J. Org. Chem, Vol. 72, No. 21, 2007 7857